Dai Han Pharmaceutical Co (XKRX:023910) Construction In Progress : ₩13,263 Mil (As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Dai Han Pharmaceutical Co Construction In Progress?

Dai Han Pharmaceutical Co's quarterly construction in progress increased from Sep. 2023 (₩12,351 Mil) to Dec. 2023 (₩15,484 Mil) but then declined from Dec. 2023 (₩15,484 Mil) to Mar. 2024 (₩13,263 Mil).

Dai Han Pharmaceutical Co's annual construction in progress declined from Dec. 2021 (₩8,857 Mil) to Dec. 2022 (₩3,225 Mil) but then increased from Dec. 2022 (₩3,225 Mil) to Dec. 2023 (₩15,484 Mil).

Dai Han Pharmaceutical Co Construction In Progress Historical Data

The historical data trend for Dai Han Pharmaceutical Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dai Han Pharmaceutical Co Construction In Progress Chart

Dai Han Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Construction In Progress

Get a 7-Day Free Trial

3,562.34

1,995.40

8,856.74

3,224.83

15,484.46

Dai Han Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Construction In Progress	Get a 7-Day Free Trial															2,810.26	7,212.08	12,351.36	15,484.46	13,262.93

Dai Han Pharmaceutical Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Dai Han Pharmaceutical Co (XKRX:023910) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dai Han Pharmaceutical Co Ltd (XKRX:023910) » Definitions » Construction In Progress

Traded in Other Exchanges

N/A

Address

8-3, 4-Ga Yangpyeong-dong, Yeongdeungpo-gu, Seoul, KOR

Website

http://www.daihan.com

Dai Han Pharmaceutical Co Ltd is a South Korea based company engages in the manufacture, supply, and distribution of pharmaceutical products such as infusions, injections, drugs used in contrast media, drugs used for external uses and quasi-drugs.

Dai Han Pharmaceutical Co (XKRX:023910) Headlines

No Headlines